GlaxoSmithKline (GSK ... controller of Germany’s Stada and owner of UK consumer products maker Thornton & Ross. Stada already announced earlier this month it would buy a small portfolio of ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK's move to enter into a joint venture with Pfizer on the consumer product side added further scale to an already well-positioned consumer group and set up the division for the July 2022 demerger.

For GSK’s Ramakrishnan, who has served as the company's CDTO since 2021, the biggest challenge was helping her company get a ...

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today. The company’s shares opened today at ...

GlaxoSmithKline has announced ... the minority buy-out of the consumer healthcare business and a series of non-core product divestments.” Eisai has retreated from the optimistic view of sales ...

GlaxoSmithKline has rejected three Unilever offers to buy its consumer goods division, including one worth £50bn. GSK said the proposals "fundamentally failed" to reflect the value of the division.

Though GSK is definitely not the best large-cap drugmaker to have in one's portfolio, we believe there is potential for its ...

The product that helped revive GSK prevents a common seasonal bug ... GSK has completed its separation from the ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

Now that its hand has been revealed, there is no question that Unilever will do its best to acquire the consumer division of GlaxoSmithKline as it completes its demerger. Its £50bn offer may rise ...